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Abstract: This research focused on obtaining eicosapentaenoic acid (EPA, 20:5 n-3) and
docosahexaenoic acid (DHA, 22:6 n-3) (EPA+DHA) concentrates from refined commercial salmon
oil (RCSO). Independent variables of the complexation process were optimized by means of the
application of response surface methodology (RSM) in order to obtain the maximum content of
such fatty acids (FAs). As a result of employing the optimized conditions for all the variables (6.0,
urea:FA content ratio; −18.0 ◦C, crystallization temperature; 14.80 h, crystallization time; 500 rpm,
stirring speed), high contents of EPA and DHA could be obtained from RCSO, achieving increases
of 4.1 and 7.9 times in the concentrate, with values of 31.20 and 49.31 g/100 g total FA, respectively.
Furthermore, a 5.8-time increase was observed for the EPA + DHA content, which increased from
13.78 to 80.51 g/100 g total FA. It is concluded that RCSO can be transformed into a profitable source
of EPA and DHA (EPA+DHA), thus leading to a product with higher commercial value.
Keywords: refined commercial salmon oil; n-3 long-chain polyunsaturated fatty acids (n-3 LCPUFAs)
concentration; EPA; DHA; EPA+DHA; total FA yield; process variable maximization; response surface
methodology (RSM); multiple response optimization; desirability function
1. Introduction
In recent years, it has been recognized that the consumption of eicosapentaenoic acid (EPA)
is associated with a low prevalence of coronary, circulatory, and inflammatory diseases [1–4].
Furthermore, docosahexaenoic acid (DHA) has been associated with fetal development, the prevention
of neurodegenerative diseases, and the correct functioning of the nervous system and visual
organs in the fetus [5–10]. According to the Food and Agriculture Organization/World Health
Organization (FAO/WHO) [1], the recommended intake of EPA+DHA is at least 250 mg/day
for adult males and non-pregnant/non-lactating adult females. Interestingly, the optimal brain
development of children would need a 150 mg/day diet of such fatty acids. EPA+DHA concentrates
may be produced by various methods, such as supercritical fluid chromatography, supercritical
fluid fractionation, molecular distillation, silver complexation, enzymatic methods, and urea
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complexation [11,12]. Among them, complexation with the urea can be considered as the most
efficient method, since polyunsaturated fatty acids (PUFAs) may be separated from saturated and
monounsaturated ones by means of an economic process at low temperature [13–18]. The present
research was focused on the employment of refined commercial salmon oil (RCSO) as a profitable
source of EPA+DHA concentrates, which in time could lead to a product of higher commercial
value. For it, independent variables of the urea adduction reaction conditions (urea:FA content ratio,
crystallization time and temperature, and crystallization stirring speed) were optimized by response
surface methodology (RSM) in order to achieve the maximum content of EPA, DHA and EPA+DHA.
Additionally, the quality of the starting salmon oil was determined and evaluated.
2. Results
2.1. Characterization of the Initial Refined Commercial Salmon Oil
Results for the composition of RCSO reported that the most abundant fatty acids were 18:1 9c
(29.61%), 18:2 9c, 12c (16.69%), and 16:0 (13.74 %) followed by EPA (7.53%) and DHA (6.25%) (g/100 g
total FA). The total value of saturated fatty acids (SFAs) was 21.28%, which was composed mainly
of palmitic, stearic, and myristic acids (Table 1). Special interest is the confirmation of the absence of
phytanic acid within the lipid composition of RCSO. This fatty acid has been linked to neurological
disorders in some people, but it is also associated with the prevention of metabolic syndrome or type 2
diabetes [19].
Table 1. Composition of fatty acids in (RCSO) and the optimized concentrate from RCSO (g/100 g
total FA) *.
FA or FA Groups RCSO RCSO Optimum
12:0 0.07 Nd
14:0 3.19 0.12
15:0 0.20 0.09
16:0 13.74 Nd
16:1 9t 0.15 Nd
16:1 7c Nd Nd
16:1 9c 4.66 0.51
16:1 11c Nd Nd
16:1 13c Nd Nd
17:0 0.13 0.10
17:1 10c 0.56 1.28
18:0 3.69 0.28
18:1 9c 29.61 0.59
18:1 11c 3.69 0.04
18:2 9t, 12t Nd Nd
18:2 9c, 12c 16.69 7.48
18:2 9c, 15c Nd Nd
18:3 6c, 9c, 12c 0.22 1.09
20:0 0.26 Nd
18:3 9c, 12c, 15c 3.25 2.60
20:1 5c Nd Nd
20:1 8c Nd Nd
20:1 11c 1.60 Nd
18:4 6c, 9c, 12c, 15c Nd Nd
20:2 11c, 14c 0.79 0.05
20:3 8c, 11c, 14c 0.30 1.16
20:3 11c, 14c, 17c 0.12 0.03
20:4 8c, 11c, 14c, 17c 0.40 1.37
22:1 13c 0.21 Nd
20:5 5c, 8c, 11c, 14c, 17c 7.53 31.20
24:1 15c Nd Nd
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22:5 7c, 10c, 13c, 16c, 19c 2.69 2.70
22:6 4c, 7c, 10c, 13c, 16c, 19c 6.25 49.31
Total SFAs 21.28 0.59
Total MUFAs 40.48 2.42
Total PUFAs 38.24 96.99
Total n-3PUFAs 20.45 87.21
Total n-3LCPUFAs 18.08 85.82
EPA+DHA 13.78 80.51
* Abbreviations employed: DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), FA (fatty acid), SFAs (saturated
fatty acids), MUFAs (monounsaturated fatty acids), RCSO (refined commercial salmon oil), n-3LCPUFAs (n-3 long
chain polyunsaturated fatty acids), Nd (not detected).
Values obtained for the oxidative stability of RCSO were: peroxide value (PV) = 5.23 ± 0.05 meq.
active oxygen kg−1 oil; p-anisidine value (pAV) = 6.84 ± 0.46; and total oxidation value
(TOTOX) = 17.30 ± 0.40 and free fatty acids (FFA) = 0.30 ± 0.01 g oleic acid/100 g oil. Previous studies
performed on refined salmon oil samples [18] indicated average values of PV= 3.54 ± 0.16 meq active
oxygen kg−1 oil; p-anisidine value (pAV) = 5.14 ± 1.02 and FFA= 0.23 ± 0.00 g oleic acid/100 g oil. and
at and 12.22 ± 1.34, respectively.
2.2. Effect of Process Variables on Total FA Yield, EPA Contents, and DHA Contents of RCSO Concentrate
2.2.1. Refined Commercial Salmon Oil Concentrate
According to the experimental design, showed in Table 2, 28 assays were performed to obtain
different refined commercial salmon oil concentrates. This table reports the experimental values
obtained for the different response variables: R1 (total FA yield; g FA in the non-urea complexing
fraction/100 g initial saponified oil FA), R2 (EPA content; g/100 g total FA), and R3 (DHA content;
g/100 g total FA) of RCSO concentrate. Table 2 also includes the predicted values for the described
corresponding variables, whereas the experimental values were replaced by the application of the
model (R1’, R2’, and R3’ values, respectively). As a result, all the independent variables (A: urea/FA
content ratio, w/w; B: crystallization temperature, ◦C; C: crystallization time, h; D: stirring speed, rpm)
significantly affected (p < 0.05) the response variables during the urea complexation process. On the
other hand, the enrichment of EPA and DHA in concentrates varied inversely according to total FA
yield, obtaining correlation coefficient values (r) of −0.7756 and −0.7185, respectively.
Table 2. Values obtained for the experimental and predicted response variables of RCSO concentrate
by central composite rotatable design 24 + star based on the response surface methodology 1.
Run Process Variables
* Response Variables
**
Experimental Values Predicted Values
A B C D R1 R2 R3 R1’ R2’ R3’
1 1.5 −15 14.3 200 40.44 10.47 11.04 33.77 13.77 14.00
2 4.5 −15 14.3 200 12.64 28.41 44.38 12.23 28.09 45.89
3 1.5 15 14.3 200 48.71 9.22 9.52 40.35 9.52 10.23
4 4.5 15 14.3 200 17.45 25.09 32.69 18.82 23.85 26.94
5 1.5 −15 36.8 200 36.25 10.46 11.13 29.02 13.22 15.24
6 4.5 −15 36.8 200 10.44 24.42 55.91 21.55 27.55 47.14
7 1.5 15 36.8 200 4.22 7.96 8.18 20.22 8.98 11.47
8 4.5 15 36.8 200 18.12 24.87 30.47 12.76 23.30 28.18
9 1.5 −15 14.3 600 41.74 10.23 10.89 44.89 14.52 14.71
10 4.5 −15 14.3 600 12.77 30.20 46.43 12.14 28.84 46.61
11 1.5 15 14.3 600 78.45 9.02 9.41 68.43 10.27 10.94
12 4.5 15 14.3 600 16.11 25.16 34.34 21.40 24.60 27.65
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13 1.5 −15 36.8 600 45.49 9.91 10.06 40.14 13.97 15.96
14 4.5 −15 36.8 600 9.86 27.56 48.55 7.17 28.30 47.85
15 1.5 15 36.8 600 58.94 7.84 7.91 48.30 9.73 12.18
16 4.5 15 36.8 600 12.64 23.05 28.93 15.33 24.05 28.89
17 0 0 25.5 400 57.38 6.33 6.39 67.84 -0.77 0.94
18 6 0 25.5 400 15.86 25.45 30.43 13.34 27.88 49.55
19 3 −30 25.5 400 12.21 29.26 44.37 19.61 24.94 36.61
20 3 30 25.5 400 33.82 13.52 14.65 34.36 16.45 13.88
21 3 0 3.05 400 12.71 20.41 22.67 25.65 21.24 24.00
22 3 0 48.0 400 16.31 23.01 28.93 14.83 20.15 26.49
23 3 0 25.5 0 19.11 22.62 25.72 13.39 19.95 24.53
24 3 0 25.5 800 16.47 26.07 33.39 27.09 21.44 25.95
25 3 0 25.5 400 20.77 22.43 25.82 20.24 20.69 25.24
26 3 0 25.5 400 20.74 21.40 25.20 20.24 20.69 25.24
27 3 0 25.5 400 17.20 24.00 29.15 20.24 20.69 25.24
28 3 0 25.5 400 22.74 18.23 20.23 20.24 20.69 25.24
Equations R2 Adjusted
Total FA yield = 57.60 − 19.47A + 0.26B − 0.87C + 0.08D + 2.26AA+ 0.01BB + 0.21AC
− 0.02AD − 0.02BC + 0.001BD 0.72(1)
EPA = −0.90 + 9.53A − 0.14B − 0.79AA 0.84(2)
DHA = −1.19 + 8.10A + 0.17B − 0.19AB 0.81(3)
EPA+DHA = 3.52 + 12.88A − 0.52B 0.80(4)
1 Central composite design: 24 + star, which studies the effects of 4 factors in 28 runs based on the RSM. * Independent
variables: A (urea/FA content ratio, w/w), B (crystallization temperature, ◦C), C (crystallization time, h), and D
(stirring speed, rpm).** Response variables: R1 (total FA yield, g FA in the non-urea complexing fraction/100 g initial
saponified oil FA), R2 (EPA content, g/100 g total FA), and R3 (DHA content, g/100 g total FA). Predicted response
variables: R1’, R2’, and R3’.
2.2.2. Effect of Process Variables on EPA, DHA, and EPA+DHA Content and Total FA Yield:
Pareto Charts and RSM Analysis
Pareto charts (Figure 1) were obtained for the different dependent variables as a function of
the concentrate processing variables from RCSO; furthermore, the linear, quadratic, and interaction
terms in the second-order polynomial were used to generate a three-dimensional response surface
graph. Panel (A) indicates that the total FA yield (R1) of concentrates was dependent (p < 0.05)
on the linear terms of the urea:FA content ratio (A), crystallization temperature (B), crystallization
time (C), stirring speed (D), the quadratic terms AA and BB, and the interactions terms AD, BD, BC,
and AC. Figure 1 (Panel B) shows the response surface of the urea complexation process for the total
FA yield. The total FA yield decreased when the urea:FA content ratio increased and the crystallization
temperature decreased. A similar result was found for the total FA yield effect in concentrate obtained
from a by-product of rainbow trout processing where the total FA yield presented a minimum value
in the response surface analysis when considering high urea:FA content ratios, at low crystallization
temperature levels and stirring speeds, and at intermediate levels of crystallization time [17]. In the
case of the EPA content (Figure 1, Panel C), the Pareto charts showed that certain linear terms—the
urea:FA content ratio (A), crystallization temperature (B), and the quadratic urea:FA content ratio
(AA)—provided a significant effect (p < 0.05). However, linear terms such as the crystallization
time (C) and stirring speed (D) did not produce significant changes (p > 0.05). Figure 1 (Panel D)
exhibits the response surface of the urea complexation process for EPA content. It was found that
the EPA content increased with the urea:FA content ratio while it decreased as the crystallization
temperature increased. For the DHA content (Figure 1, Panel E), the Pareto charts reported that
the linear terms of the urea:FA content ratio (A), crystallization temperature (B), and the interaction
between the urea:FA content ratio and the crystallization temperature (AB) revealed a significant effect
(p < 0.05). The DHA content increased when the urea:FA content ratio increased, while it decreased
as the crystallization temperature increased (Figure 1, Panel F). Finally, concerning the EPA+DHA
Molecules 2019, 24, 1642 5 of 12
content, the urea:FA content ratio showed a positive effect, whereas the crystallization temperature
had a negative effect (p < 0.05) (Figure 1, Panel G). These results agree with those obtained by authors
concerning the employment of the Asian catfish (Pangasius bocourti) and by-product of rainbow trout
oil, which reported an inverse relationship between the urea:FA content ratio and the crystallization
temperature on the urea concentrate process [16,17]. When the urea:FA content ratio increased and the
crystallization temperature decreased as result, high values were obtained for DHA in the non-urea
complexing fraction, as well as a great retention of saturated and monounsaturated FA in the urea
crystal adducts. In this case, similar results for the EPA content were found. In all the cases, the EPA,
DHA, and EPA+DHA contents did not significantly varied depending on the stirring speed (p > 0.05).
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Figure 1. Pareto charts and response surfaces for the effects of different process variables: Panels in
total FA yield (%, panels A,B), EPA content (g/100 g total FA, panels C,D), DHA content (g/100 g total
FA, panels E,F), EPA+DHA content (g/100 g total FA, panels G,H). A: urea/FA contents ratio, w/w; B:
crystallization temperature, ◦C; C: crystallization time, h; and D: stirring speed, rpm).
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2.2.3. Models Obtained for the Concentration of EPA, DHA, and EPA+DHA
Equations obtained for the experimental process variables of the response surface model calculated
by multiple regression are shown in Table 2. According to the equations obtained, all the response
variables were found to be dependent on the same process variables expressed in the Pareto analysis
(Figure 1). The four RCSO concentrated models had an adjusted R2 by degrees of freedom of 72.0% for
total FA yield (Equation (1)), 84.0% for EPA (Equation (2)), 81.0% for DHA (Equation (3)), and 80.0%
for EPA+DHA (Equation (4)). Such values reported that the models adequately represented the
variability of the results. Since the p-values obtained for lack-of-fit in the ANOVA study (0.014, 0.35,
0.19, 0.28; Equation (1) to Equation (4), respectively) was greater or equal to 0.05, except for Equation (1),
the model appears to be adequate for the observed data at the 95.0% confidence level.
2.2.4. Independent Variables and Multiple Response Optimization
Table 3 (part a) shows the optimization of the independent variables for the response variables
(EPA, DHA, and EPA+DHA) of the urea complexation process. The optimum values of dependent
variables for EPA, DHA, and EPA+DHA content were 33.01, 76.81, and 98.85 (g/100 g total FA),
respectively. In all the cases, a tendency toward the same values for the urea:FA content ratio and
crystallization temperature was observed, so that the optimum EPA, DHA, and EPA+DHA contents
were obtained.
Table 3. Process variables * optimization and multiple response optimization of the response variables.
Part a) Optimization of the Process Variables
Dependent Variables Process Variables StationaryPoint
Optimum
Value **
A B C D
EPA 5.99 −29.79 3.05 599.00 Maximum 33.01
DHA 6.00 −29.98 48.05 108.30 Maximum 76.81
EPA+DHA 6.00 −29.95 47.79 271.36 Maximum 98.85
Part b) Multiple Response Optimization of the Response Variables
Dependent Variables Process Variables StationaryPoint
Predicted
Value **
A B C D
EPA
5.84 −17.69 14.83 453.36 Maximum
30.71-
DHA 62.94
EPA+DHA 90.07
Maximum desirability 1.0
Part c) Experimental Validation of the Multiple Response Optimization of the Dependent Variables
Dependent Variables Process Variables StationaryPoint
Experimental
Value **
A B C D
EPA
6.00 −18 14.80 500 Maximum
31.20
DHA 49.31
EPA+DHA 80.51
* Process variables (A, B, C, and D) as expressed in Table 2. ** Values expressed as g/100 g total FA.
Table 3b shows the levels of factors that maximized the EPA, DHA, and EPA+DHA contents
(g/100 g total FA) by means of multiple response optimization and the stationary point that predicted
a maximum of 30.71, 62.94, and 90.07 (g/100 g total FA) in EPA, DHA, and EPA+DHA, respectively.
Maximum desirability score of 1 (range, 0–1) was attained. A maximum predicted value could be
obtained, provided that the following process conditions were applied: 5.84 (urea: FA content ratio),
−17.69 ◦C (crystallization temperature), 14.83 h (crystallization time), and 453.00 rpm (stirring speed).
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Figure 2 (panels A, B) shows the contours and estimated response surface of the urea:FA content
ratio and crystallization temperature of the combination of factors levels to maximize the desirability
function for RCSO concentrate. It is observed that the highest desirability values were reached by
taking into account the high values of the urea:FA content ratio and the low crystallization temperature
values. These results were similar to those previously reported for rainbow trout belly oil [17], where a
maximum desirability score of 0.91 was obtained in the multiple response optimization of EPA,
DHA and EPA+DHA contents. Furthermore, the predictive values of 32.50, 37.00, and 67.70 (g/100 g
total FA) in the by-product concentrate of rainbow trout oil, respectively, were obtained. As a result,
the following process conditions were applied in such study: 4.21 (urea:FA contents ratio), −15.00 ◦C
(crystallization temperature), 24.0 h (crystallization time), and 1000 rpm (stirring speed).
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2.2.5. Validation of the Optimized Process and Characterization of the EPA+DHA Content Obtained
Table 3c shows the validation of multiple response optimization after experimentally performing
the process conditions. For EPA content, comparison of the predicted value and the value obtained
experimentally showed that both values were similar (i.e., 30.71 and 31.20 g/100 g total FA, respectively);
however, the experimental value of DHA content was substantially different from the predictive value
(49.31 and 62.94 g/100 g total FA, respectively). Experimental values performed on rainbow trout belly
oil [17] were shown to be similar to the predicted values obtained in the current study for EPA and
DHA (36.10 and 47.70 g/100 g of total FA, respectively). In the experimental validation, an 80.51 g/100 g
total FA value was obtained for the EPA+DHA content, which agrees with the value revealed by other
authors who obtained a stationary point of 89.38% for the EPA+DHA content [14].
2.3. Composition of FA in the RCSO Optimized Concentrate after Validation
Table 1 shows the FA composition of the RCSO compared to the composition of FA from the
validated optimum concentrate. Optimization process validation was performed experimentally by
combining the factors levels in which the optimal EPA+DHA content was attained (Table 3b,c). In these
experiments, the effect of the urea complexation process on the composition of FA and FA groups in
the optimized concentrate (g/100 g FA) after validation can be observed. When compared to the initial
RCSO, there was a marked increase in the concentration of total PUFAs (96.99%) and a substantial
decrease in the concentration of SFAs (0.59%) and MUFAs (2.42%). Furthermore, the predominant FAs
in the optimum concentrate oil were EPA, DHA, and EPA+DHA (31.20, 49.31, and 80.51 g/100 g total FA,
respectively). The urea complexation under the optimization process conditions has revealed a high
efficiency, since a marked increase of total PUFAs from 38.24 to 96.99 g/100 g total FA could be observed;
this increase was 1.21 times higher than that reported by Pando et al. [18]. Additionally, the total
EPA+DHA final content was 2.5 times higher than that reported for refined salmon oil concentrate
without the optimization process [18].
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3. Discussion
In the present research, the distribution of SFAs in RSCO showed that this FA group was mainly
composed of palmitic, stearic, and myristic acids. Similar values have been established for the SFAs
group from crude commercial salmon oil [18]; interestingly, refined commercial salmon oil and Asian
catfish oil also showed these three FA as the major ones, but a higher presence of stearic acid compared
with myristic acid was detected in our study [16,18]. Among the MUFAs, the most abundant in the
present study were 18:1 9c, 16:1 9c, 18:1 11c, and 20:1 11c. The total n-3 long chain polyunsaturated fatty
acids (n-3 PUFAs) content was 1.14 times higher than the content of total n-6 PUFAs, showing values
higher than those previously reported in different kinds of oils obtained crude commercial salmon,
and rainbow trout (Oncorhynchus mykiss) [18,20]. The analysis of process variables shows a high
recovery performance of RCSO concentrate when the urea:FA content ratio has the lowest value,
and the value considered for the crystallization temperature is the highest. The results show a higher
content of EPA and DHA when the total FA yield is lower, indicating that this experiment eliminated
most of the SFAs and MUFAs from the starting oil, only leaving a small fraction of such acids in the urea
non-complexed fraction. Similar values have been observed by other authors [17,21], who reported
major yields with higher stirring speed, corroborating a significant effect of the stirring speed on the
total FA yield in the urea complexation process (p < 0.05). Current results show an inverse relationship
between the urea:FA content ratio and the crystallization temperature on the DHA content, which is a
conclusion that has already been than those reported by several authors, whose employed different
oils from marine origin such as seal blubber oil, tuna oil, Asian catfish oil, and a by-product of rainbow
trout [13,14,16,17]. In this case, results similar for EPA content were found. As an explanation for
this, it could be argued that the urea:FA content ratio has a significant positive effect (p < 0.05) on the
concentration of EPA and DHA, probably as a result of increasing the concentration of urea with respect
to that of FFA; consequently, this would lead to an increase of the number of adducts formed between
the flat structures of SFA and urea molecules, this favoring the formation of hexagonal complexes and
crystals [13], and leading to an increased concentration of EPA and DHA in the non-urea complexing
solution. Previous studies on tuna oil concentrates have revealed that the regression models for total
FA yield and total EPA+DHA content were highly significant with satisfactory R2 coefficients [14,22].
The present data proved that the urea complexation under the optimization process conditions has
shown to be highly efficient, since an increase in the total PUFAs content from 38.24 to 96.99 g/100 g total
FA could be reached, which was 1.2 times higher than that reported by Pando et al. [18]. Additionally,
the total EPA+DHA final content was 2.5 times higher than that reported for refined salmon oil
concentrate without applying an optimization process [18]. On the other hand, the oxidative and
hydrolytic stability parameters (PV, pAV, TOTOX, and FFA) indicate that the quality of the oil used in
this study was included within the acceptable quality limits for edible fats and oils of marine origin
according to the Chilean Food Sanitary Regulations. Government institutions and trade associations,
such as the Council for Responsible Nutrition (CRN) and the Global Organization for EPA and DHA
Omega-3s (GOED), have set strict guidelines for marine oil quality and safety parameters. According to
the previously described recommended values [23,24], the starting RCSO can be considered included in
the 98% of fish oil products compliant with the PV limit of 10 meq. active oxygen kg−1 oil set by British
Pharmacopeia Fish Oil Type I, European Union (EU) Pharmacopeia Fish Oil Type I, and Australian
government guidelines. Furthermore, salmon oil samples were compliant with the pAV limit of
15 set by British and EU Pharmacopeia Fish Oil Type II, as well as the pAV limit of 20 set by the
GOED, Canada Natural Health Product Directorate (NHP), United States Pharmacopeia, and Codex
Alimentarius Commission, Food and Agriculture Organization of the United Nations (CODEX/FAO).
Thus, the primary and secondary lipid oxidation levels of RCSO are not exceeding the regulatory
thresholds in the testing peroxide values and p-anisidine values. Interestingly, such lipid oxidation
scores can be considered similar to those previously obtained for refined salmon oil samples [18] and
salmon oil [24]. On the other hand, the FA composition of the RCSO showed that most abundant FAs
were C18:1 9c, 18:2 9c, 12c, and C16:0, followed by EPA and DHA. The value of the total SFAs was
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found to be 21.28% in RCSO. Concerning PUFAs, the most abundant in RCSO concentrates were DHA,
EPA, and 18:2 9c, 12c.
4. Materials and Methods
4.1. Materials and Chemicals
Refined commercial salmon oil was provided by Fiordo Austral S.A. (Puerto Montt, Chile).
Fatty acid methyl ester (FAME) standards, fatty acid (FA) standards, and C23:0-methyl ester (2COT
N-23M-A29-4 NU-CHECK-PREP-INC) were obtained from NU-CHECK-PREP, INC (Elysian, MN,
USA). All the solvents and chemicals used (including urea, ethanol, α-tocopherol, and n-hexane) were
of analytical grade (Merck, Santiago, Chile).
4.2. Characterization of Refined Commercial Salmon Oil
Initial RCSO characterization was carried out by chemical analyses. For it, the following standard
Association of Official Analytical Chemists (AOAC) and official methods [25] were carried out: peroxide
value (PV; method Cd 8b-90:1-2), p-anisidine value (pAV; method Cd 18-19:1-2), and total oxidation
value (TOTOX; method Cg 3-91) and free fatty acids (FFA) contents (method Ca 5a-40:1).
4.3. FA Composition of the RCSO and n-3 LCPUFA Concentrates
For analyzing the FA composition of the RCSO and the different LCPUFA concentrates,
a methylation process was performed to obtain FAMEs. For it, a two-step process was performed,
according to previous research [18,26]. FAME analysis was carried out on an HP 5890 series II GLC
with a flame ionization detector (FID) with the injection system split. A fused silica capillary column
(100 m length × 0.25 mm × 0.2 µm film thickness) coated with SPTM-2560 (Supelco, Bellefonte, PA,
USA) was used [18,26–29]. DataApex ClarityTM software (DataApex Ltd., Prague, Czech Republic) for
chromatogram analysis was applied. The reference standard NU-CHEK GLC463 was used to identify
the FA profiles. The concentration of the different FAME was determined from the calibration curves
by assessment of the peak/area ratio. The quantification of all the individual FAs (g/100 g total FA) was
achieved by employing C23:0 methyl ester as the internal standard according to the (AOCS Official
Method (Ce 1j-7, 2009) [26].
4.4. n-3 LCPUFA Concentrates from RCSO
The procedure included salmon oil saponification, which was in agreement with other
authors [17,18,30]. Concentrate from RCSO was prepared by FFA collection, the formation of
urea FFA inclusion complexes, and the extraction of free n-3 LCPUFA. For it, the urea complexation
method was carried out by 28 experimental runs with different urea:FA content ratios (0 to 6 w/w),
crystallization temperatures (−30 to 30 ◦C), crystallization times (0 to 48 h), and stirring speeds (0 to
800 rpm). The FFAs were mixed with urea and 95 % ethanol, and the mixture was subsequently
stirred and heated at 60 ◦C with magnetic stirring. Then, it was cooled with constant stirring to
different conditions of temperature and time as described in the experimental design. The crystals
formed were separated from the liquid phase by filtration with a Whatman No.1 paper. The non-urea
complexing fraction was diluted with 100 mL of distilled water by each 10 g, acidified to pH 4.5 with
6 N HCl, and washed in a separating funnel with hexane (400 mL). The hexane phase was filtered with
anhydrous sodium sulfate in a Whatman No.1 paper, and the solvent was partially removed using
a rotatory evaporator at 40 ◦C under vacuum [16,17]. The resulting n-3 LCPUFA concentrates were
stored at −80 ◦C with 0.5% of α-tocopherol under nitrogen atmosphere until use for further analysis.
4.5. Experimental Design and Optimization Procedure
A rotational central composite design 24 + star, with 4 factors and 5 levels, was carried out, with 28
experimental runs that included 4 repetitions of the central point based on the RSM. The following
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conditions for the independent variables were considered (Table 1): urea:FA content ratio (variable
A: 0 to 6 w/w), crystallization temperature (variable B: −30 to 30 ◦C), crystallization time (variable C:
3.05 to 48.0 h), and stirring speed (variable D: 0 to 800 rpm). On the basis of the non-urea complexing
fraction, the following response variables (R variables) of the experiment design were chosen: total
FA yield (variable R1: g FA in the non-urea complexing fraction/100 g initial RCSO), EPA content
(variable R2: g/100 g total FA in concentrate), and DHA content (variable R3: g/100 g total FA in
concentrate). Four replicates were carried out at the central point of the experimental design in
order to evaluate the experimental error. All experiments were performed randomly to minimize
the effect of unexplained variability in responses resulting from extraneous factors [31]. In order
to obtain response surfaces, multiple regression equations were fitted to the responses obtained by
discarding non-significant terms (p > 0.05) to obtain response surfaces. To maximize the desirability
function a multiple response optimization was performed to optimize several responses simultaneously,
which maximized the desirability function scores that ranged between 0 and 1 [32]. The RSM was used
to optimize and maximize the response variables, and a quadratic polynomial regression model was
assumed for predicting individual Y variables. The model proposed for each Y value was as according
to Equation (5):
Yi = β0 +
4∑
i=1
βiXi +
4∑
i=1
βiiX
2
i +
3∑
i=1
4∑
j=i+1
βi jXiX j + ε, (5)
where β0, βi, and βii represent the intercept, linear, and quadratic coefficients, respectively;
βij corresponds to the interaction coefficient terms for the interaction of variables i and j; Xi represents
the independent variables; and E denotes to the random error [31,32].
4.6. Statistical Analysis
Multiple regression analysis, ANOVA. canonical, and ridge maximum of data in the response
surface regression (RSREG) procedure was used. The estimated response surface and contours of the
estimated response surface were developed using the fitted quadratic polynomial equations obtained
from the response surface regression (RSREG) analysis, holding the independent variables with the
least effect on the response at a constant value and changing the levels of the other two variables [31,32].
A multiple-response optimization was performed to assess the combination of experimental factors that
simultaneously optimize several responses; as a result, maximization of the desirability function was
obtained, this function ranging from 0 to 1 [32]. Analyses were performed in triplicate considering the
standard deviation of each sample. The lack-of-fit test was carried out by comparison of the variability
of the current model residuals with the variability between observations at replicate settings of the
factors [31,32]. Statgraphics Centurion XV.II (Manugistics Inc., Rockville, USA) was used.
5. Conclusions
The physical–chemical analyses of refined commercial salmon oil indicate that it is a good quality
raw material that complies with the characteristics that are typical of oils of marine origin. A high
concentration of EPA and DHA was obtained from RCSO, achieving an increase of up to 4.1 and 7.9
times in the concentrate, with values of 31.20 and 49.31 g/100 g total FA, respectively. Interestingly
a 5.8-time increase was observed for the EPA+DHA content, from 13.78 to 80.51 g/100 g total FA.
Therefore, it has been proved that it is possible to maximize the EPA and/or DHA content by the
optimization of the variables in the urea inclusion process. The results of this study could serve as a
basis for the food and nutraceutical industry, whose processes with clean technologies can develop new
functional foods enriched with EPA and DHA. Furthermore, the consumption of such new functional
foods would be likely to produce a positive and profitable impact on the health of a wide range of
consumers such as pregnant women, infants, and older adults in general.
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